A nomogram for screening sarcopenia in Chinese type 2 diabetes mellitus patients

[1]  R. Simó,et al.  The Association Between Diabetes Mellitus and Risk of Sarcopenia: Accumulated Evidences From Observational Studies , 2021, Frontiers in Endocrinology.

[2]  S. Cha,et al.  Waist-To-Hip Ratio Predicts Abnormal Overnight Oximetry in Men Independent of Body Mass Index , 2021, Frontiers in Cardiovascular Medicine.

[3]  Kaiyan Hu,et al.  Prevalence and risk factors of sarcopenia in patients with diabetes: A meta-analysis. , 2021, The Journal of clinical endocrinology and metabolism.

[4]  Jing Zhong,et al.  Development and Validation of a Nomogram for Predicting Sarcopenia in Community-Dwelling Older Adults , 2021, Journal of the American Medical Directors Association.

[5]  Yi Shang,et al.  Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis , 2021, Nutrients.

[6]  Ruoxin Xu,et al.  The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis , 2021, Diabetology & Metabolic Syndrome.

[7]  Seung Min Chung,et al.  Prevalence of Sarcopenia and Its Association With Diabetes: A Meta-Analysis of Community-Dwelling Asian Population , 2021, Frontiers in Medicine.

[8]  Yong Li,et al.  Sarcopenia prevalence and associated factors among older Chinese population: Findings from the China Health and Retirement Longitudinal Study , 2021, PloS one.

[9]  G. Riccardi,et al.  A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors , 2021, Nutrients.

[10]  Xiaoqi Cai,et al.  Relationship between lactate dehydrogenase and albuminuria in Chinese hypertensive patients , 2020, Journal of clinical hypertension.

[11]  S. Chuang,et al.  The relationship between resting heart rate and new‐onset microalbuminuria in people with type 2 diabetes: An 8‐year follow‐up study , 2020, Diabetic medicine : a journal of the British Diabetic Association.

[12]  Ting Huang,et al.  Risk Factors for Sarcopenia in the Elderly with Type 2 Diabetes Mellitus and the Effect of Metformin , 2020, Journal of diabetes research.

[13]  Mina Wang,et al.  Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments , 2020, Frontiers in Endocrinology.

[14]  G. Lian,et al.  Relationship between high‐normal albuminuria and arterial stiffness in Chinese population , 2020, Journal of clinical hypertension.

[15]  D. Goulis,et al.  Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis , 2020, Calcified Tissue International.

[16]  E. Roh,et al.  Sex differences in sarcopenia and frailty among community‐dwelling Korean older adults with diabetes: The Korean Frailty and Aging Cohort Study , 2020, Journal of diabetes investigation.

[17]  P. Lee,et al.  The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia , 2020, PloS one.

[18]  L. Peng,et al.  Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. , 2020, Journal of the American Medical Directors Association.

[19]  M. Azevedo,et al.  Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus , 2020, Experimental Gerontology.

[20]  Liang-di Xie,et al.  Relationship between components of metabolic syndrome and arterial stiffness in Chinese hypertensives , 2020, Clinical and experimental hypertension.

[21]  O. Bosello,et al.  Obesity paradox and aging , 2019, Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.

[22]  M. He,et al.  Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria , 2019, Aging Clinical and Experimental Research.

[23]  W. Amer,et al.  Adult anthropometry in Type 2 diabetic population: A case-control study , 2019, Pakistan journal of medical sciences.

[24]  G. Lian,et al.  Low-Grade Albuminuria Is Associated with Left Ventricular Hypertrophy and Diastolic Dysfunction in Patients with Hypertension , 2019, Kidney and Blood Pressure Research.

[25]  Tao Jie,et al.  Predicting the risk of sarcopenia in elderly patients with patellar fracture: Development and assessment of a new predictive nomogram , 2019, bioRxiv.

[26]  Zhi-Xiang Xu,et al.  Activation of Anxiogenic Circuits Instigates Resistance to Diet-Induced Obesity via Increased Energy Expenditure. , 2019, Cell metabolism.

[27]  Yuichiro Yamada,et al.  Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients , 2018, Journal of diabetes investigation.

[28]  J. Batsis,et al.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies , 2018, Nature Reviews Endocrinology.

[29]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. , 2018, Diabetes research and clinical practice.

[30]  S. Park.  Nomogram: An analogue tool to deliver digital knowledge. , 2018, The Journal of thoracic and cardiovascular surgery.

[31]  J. Reginster,et al.  Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis , 2017, PloS one.

[32]  Taotao Wang,et al.  Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly , 2016, Scientific Reports.

[33]  L. Peng,et al.  Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. , 2014, Journal of the American Medical Directors Association.

[34]  Han-min Zhu,et al.  A cross-sectional study of loss of muscle mass corresponding to sarcopenia in healthy Chinese men and women: reference values, prevalence, and association with bone mass , 2013, Journal of Bone and Mineral Metabolism.

[35]  M. Woodward,et al.  Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus , 2012, Journal of the American Heart Association.

[36]  J. Després,et al.  Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox? , 2011, Journal of the American College of Cardiology.

[37]  M. Charles,et al.  1 Pre-screening tools for diabetes and obesity-associated dyslipidaemia : comparing BMI , waist and waist hip ratio , 2007 .

[38]  Tom Greene,et al.  Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.

[39]  B. Balkau,et al.  Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study , 2006, European Journal of Clinical Nutrition.